Rigel Pharmaceuticals, Inc. (RIGL) financial statements (2022 and earlier)

Company profile

Business Address 1180 VETERANS BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments125579812911675126
Cash and cash equivalents19302376381843
Short-term investments106277652775783
Receivables1516104  0
Inventory, net of allowances, customer advances and progress billings7211   
Inventory7211   
Advances on inventory purchases 43    
Other undisclosed current assets71063213
Total current assets:1548911913711776129
Noncurrent Assets
Operating lease, right-of-use asset1018 
Property, plant and equipment2321112
Other noncurrent assets1111111
Other undisclosed noncurrent assets  26    
Total noncurrent assets:1321292223
TOTAL ASSETS:16711014813911978132
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:13112020131110
Accounts payable  46363
Accrued liabilities4474311
Employee-related liabilities  910746
Taxes payable1      
Interest and dividends payable00     
Other undisclosed accounts payable and accrued liabilities87     
Deferred revenue33 
Debt 9     
Deferred revenue and credits 316
Contract with customer, liability25 
Other liabilities14      
Other undisclosed current liabilities3518138598
Total current liabilities:64415828182334
Noncurrent Liabilities
Long-term debt and lease obligation213010    
Long-term debt, excluding current maturities202010    
Operating lease, liability111 
Liabilities, other than long-term debt53570003
Deferred revenue and credits0003
Contract with customer, liability1 
Other liabilities5355 000
Total noncurrent liabilities:7336160003
Total liabilities:137767528182337
Stockholders' equity
Stockholders' equity attributable to parent3034541101015591
Common stock0000000
Additional paid in capital1,3541,3401,3301,3191,2391,1161,083
Accumulated other comprehensive income (loss)(0)(0)0(0)(0)(0)(0)
Accumulated deficit(1,324)(1,306)(1,276)(1,209)(1,139)(1,061)(992)
Total stockholders' equity:3034541101015591
Other undisclosed liabilities and equity  191 03
TOTAL LIABILITIES AND EQUITY:16711014813911978132

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues149109594542029
Revenue, net42029
Cost of revenue(1)(1)(1)(0)(1)(0) 
Cost of goods and services sold(1)(1)(1)(0)   
Gross profit:148108584442029
Operating expenses(161)(137)(127)(117)(83)(90)(81)
Operating loss:(12)(29)(69)(73)(80)(70)(52)
Nonoperating income
(Investment Income, Nonoperating)
0143100
Interest and debt expense(5)(1)(0)    
Loss from continuing operations before income taxes:(17)(30)(66)(70)(78)(69)(52)
Income tax expense(1)      
Loss before gain (loss) on sale of properties:(18)(30)(66)(70)(78)(69)(52)
Other undisclosed net income (loss) (0)(1)(1)0  
Net loss attributable to parent:(18)(30)(67)(70)(78)(69)(52)
Other undisclosed net income available to common stockholders, basic     00
Net loss available to common stockholders, diluted:(18)(30)(67)(70)(78)(69)(51)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(18)(30)(67)(70)(78)(69)(52)
Comprehensive loss:(18)(30)(67)(70)(78)(69)(52)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)00(0)00
Comprehensive loss, net of tax, attributable to parent:(18)(30)(67)(70)(78)(69)(52)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: